Business Management - Finance/Financial

Bondholder Chatham seeks RRD to appoint a new board chairman and add new directors, to terminate its “poison pill” plan, and more. 

Revenues were $100.5 million compared to $86.6 million for the same quarter last year, an increase of $13.9 million, or 16.0%.

Action item No. 5 of the six-point ‘Path Out of the Pandemic’ plan is worthy of review by mid- and small-sized printing companies.

Transcontinental Inc. breaks down its results for the third quarter fiscal 2021, as well as its outlook for future business potential.

The annual review reviews, categorizes, sorts, counts, and charts data comparing the trailing twelve months ended this August.

The sale will allow Heidelberg to further advance its unique positioning in cloud and data-based software.

RRD has amended the Company’s existing stockholder rights plan to extend its final expiration date to August 28, 2022.

Given the continued challenges, Day International continues to face cost increases across the global supply chain.

On this episode of The Week that Was, RRD and Quad both released Q2 and YTD financials this week; RRD is embroiled in a conflict with Chatham Asset Management; and Avery Dennison will acquire Vestcom.

Chatham Asset Management wants RRD to not renew its “Poison Pill” rights plan and instead review its assets with an external advisor.